| FOLDAMICUS THERAPEUTICS, INC. | 3,986,058 | $57.6M |
| ACLXArcellx, Inc. | 394,931 | $45.3M |
| APLSApellis Pharmaceuticals, Inc. | 869,229 | $35.0M |
| TERNTerns Pharmaceuticals, Inc. | 281,614 | $14.8M |
| DAWNDay One Biopharmaceuticals, Inc. | 645,173 | $13.8M |
| VTRSViatris Inc | 211,247 | $2.9M |
| AXSMAxsome Therapeutics, Inc. | 16,009 | $2.7M |
| ABTABBOTT LABORATORIES | 22,052 | $2.2M |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | 3,811 | $2.0M |
| BMYBRISTOL MYERS SQUIBB CO | 32,473 | $1.9M |
| CORCencora Inc. | 6,129 | $1.9M |
| AZNASTRAZENECA PLC | 9,449 | $1.9M |
| GMEDGlobus Medical Inc. | 19,292 | $1.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 6,159 | $1.6M |
| GMOptec International, Inc. | 22,092 | $1.6M |
| GILDGILEAD SCIENCES, INC. | 9,707 | $1.3M |
| AUPHAurinia Pharmaceuticals Inc. | 67,626 | $1.0M |
| IDXXIDEXX LABORATORIES INC /DE | 1,652 | $920K |
| LLYELI LILLY & Co | 986 | $874K |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,130 | $847K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,672 | $741K |
| INVAInnoviva, Inc. | 24,774 | $577K |
| CSTLCastle Biosciences Inc. | 23,332 | $573K |
| MLYSMineralys Therapeutics, Inc. | 18,549 | $502K |
| MEDPMedpace Holdings Inc. | 977 | $469K |
| XERSXeris Biopharma Holdings, Inc. | 79,302 | $460K |
| IQVIQVIA Holdings Inc. | 2,550 | $424K |
| TGTXTG THERAPEUTICS, INC. | 12,617 | $419K |
| NATRNATURES SUNSHINE PRODUCTS INC | 16,419 | $394K |
| CRNXCrinetics Pharmaceuticals, Inc. | 9,518 | $346K |
| KROSKeros Therapeutics, Inc. | 30,085 | $332K |
| NEONeoGenomics Inc. | 43,460 | $322K |
| INDVIndivior Pharmaceuticals, Inc. | 9,153 | $279K |
| TBPHTheravance Biopharma, Inc. | 16,503 | $268K |
| ABUSArbutus Biopharma Corp | 58,516 | $263K |
| VERAVera Therapeutics, Inc. | 6,397 | $257K |
| BBIOBridgeBio Pharma, Inc. | 3,465 | $257K |
| MOHMolina Healthcare Inc | 1,946 | $256K |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 4,881 | $252K |
| SNDXSyndax Pharmaceuticals Inc | 10,791 | $252K |
| DFTXDefinium Therapeutics Inc. | 13,178 | $249K |
| SRRKScholar Rock Holding Corp | 4,779 | $235K |
| LQDALiquidia Corp | 6,119 | $231K |
| ELVElevance Health Inc. | 799 | $228K |
| PMPhilip Morris International Inc | 1,377 | $227K |
| VCELVericel Corp | 6,967 | $224K |
| AMPHAmphastar Pharmaceuticals, Inc. | 11,235 | $220K |
| NVONovo Nordisk A/S | 5,897 | $217K |
| CGONCG Oncology, Inc. | 3,076 | $208K |
| AGIOAGIOS PHARMACEUTICALS, INC. | 5,936 | $201K |
| USNAUSANA HEALTH SCIENCES INC | 11,015 | $192K |
| SVRASavara Inc | 34,552 | $189K |
| BHVNBiohaven Ltd. | 20,937 | $177K |
| ADMAADMA BIOLOGICS, INC. | 17,633 | $159K |
| SLSSELLAS Life Sciences Group, Inc. | 35,032 | $148K |
| ADCTADC Therapeutics SA | 39,092 | $147K |
| RNAAtrium Therapeutics Inc. | 10,512 | $141K |
| ARDXARDELYX, INC. | 19,806 | $119K |
| NEOGNEOGEN CORP | 11,382 | $106K |
| REPLReplimune Group, Inc. | 13,402 | $103K |
| ANNXAnnexon, Inc. | 14,205 | $79K |
| CMPXCompass Therapeutics, Inc. | 13,045 | $69K |
| PRMEPrime Medicine, Inc. | 15,784 | $55K |
| TSHATaysha Gene Therapies, Inc. | 11,409 | $51K |
| PGENPRECIGEN, INC. | 10,188 | $39K |